Health care stocks fell Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both shedding 0.6%.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, BioNTech (BNTX) expects full-year revenue at the low end of guidance due in part to inventory writedowns, even as variant-adapted COVID-19 vaccines helped boost Q3 results. The shares fell 0.7%.
PACS (PACS) shares tumbled 28% following a report by short-seller Hindenburg Research.
AstraZeneca (AZN) said its experimental obesity pill was well-tolerated by people with type-2 diabetes, Bloomberg reported, citing comments made by a company executive at an industry conference. AstraZeneca shares eased 0.2%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。